Jpmorgan Chase & CO Sanara Med Tech Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11,720 shares of SMTI stock, worth $349,256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,720
Previous 13,574
13.66%
Holding current value
$349,256
Previous $450,000
19.78%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SMTI
# of Institutions
51Shares Held
1.07MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$5.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$5.24 Million0.0% of portfolio
-
Stonebridge Wealth Management, LLC Oak Brook, IL120KShares$3.57 Million3.2% of portfolio
-
Geode Capital Management, LLC Boston, MA77.7KShares$2.32 Million0.0% of portfolio
-
Marshall Wace, LLP London, X071.5KShares$2.13 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $247M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...